Pediatric Neurology Research in the Twenty-First Century: Status, Challenges, and Future Directions Post-COVID-19.

Published on Dec 1, 2020in Pediatric Neurology2.89
· DOI :10.1016/J.PEDIATRNEUROL.2020.08.012
Joshua L. Bonkowsky28
Estimated H-index: 28
(UofU: University of Utah),
Gabrielle deVeber85
Estimated H-index: 85
(U of T: University of Toronto)
+ 20 AuthorsJanet S. Soul37
Estimated H-index: 37
Abstract Background 2020 marked a fundamental shift in the pediatric neurology field. An impressive positive trajectory of advances in patient care and research faced sudden global disruptions by the COVID-19 pandemic and by an international movement protesting racial, socioeconomic, and health disparities. The disruptions revealed obstacles and fragility within the pediatric neurology research mission. However, renewed commitment offers unique opportunites for the pediatric neurology research community to enhance and prioritize research directions for the coming decades. Objective and Methods The Research Committee of the Child Neurology Society evaluated the challenges and opportunities facing the pediatric neurology research field, including reviewing published literature, synthesizing publically-available data, and conducting a survey of pediatric neurologists. Results We identified three priority domains for the research mission: funding levels, active guidance, and reducing disparities. Funding Levels: to increase funding to match the burden of pediatric neurological disease; to tailor funding mechanisms and strategies to support clinical trial efforts unique to pediatric neurology; and to support investigators across their career trajectory. Active Guidance: to optimize infrastructure and strategies; to leverage novel therapeutics, enhance data collection, and improve inclusion of children in clinical trials. Reducing Disparities: to reduce health disparities in children with neurological disease; to develop proactive measures to enhance workforce diversity and inclusion, and increase avenues to balance work-life obligations for investigators. Conclusions In this uniquely challenging epoch, the pediatric neurology research community has a timely and important mission to re-engage the public and government, advancing the health of children with neurological conditions.
📖 Papers frequently viewed together
20 Authors (Robert D. Annett, ..., Andrew M. Atz)
1 Citations
44 Citations
1 Author (I B Pless)
#1Yusuke Okubo (UCLA: University of California, Los Angeles)H-Index: 12
#2Aria Fallah (UCLA: University of California, Los Angeles)H-Index: 20
Last. Hiroki Nariai (UCLA Medical Center)H-Index: 8
view all 5 authors...
Abstract Background Previous studies have shown the healthcare utilization for medically refractory epilepsy and epilepsy surgery until 2012 with disparities according to race/ethnicity and socioeconomic status. To extend these data and add other utilization information, we retrospectively investigated the nationwide trends in hospitalization and readmission during 2010–2015. Method We extracted data on inpatients who were diagnosed with epilepsy and those who received epilepsy surgery using the...
3 CitationsSource
#1Phillip L. Pearl (Harvard University)H-Index: 40
#2Jonathan W. Mink (UR: University of Rochester)H-Index: 57
Last. Roger LarsonH-Index: 2
view all 8 authors...
3 CitationsSource
#1Sandro Galea (BU: Boston University)H-Index: 132
#2Salma M. Abdalla (BU: Boston University)H-Index: 6
63 CitationsSource
#1Sara E. Grineski (UofU: University of Utah)H-Index: 25
#2Danielle X. Morales (UTEP: University of Texas at El Paso)H-Index: 10
Last. Joshua L. Bonkowsky (UofU: University of Utah)H-Index: 28
view all 5 authors...
Objective To examine disparities in the diagnosis of leukodystrophies including geographic factors and access to specialty centers. Study design Retrospective cohort study of pediatric patients admitted to Pediatric Health Information System hospitals. Patients with leukodystrophy were identified with International Classification of Diseases, Tenth Revision, Clinical Modification diagnostic codes for any of 4 leukodystrophies (X-linked adrenoleukodystrophy, Hurler disease, Krabbe disease, and me...
5 CitationsSource
#1Brian LaGrant (Cornell University)H-Index: 1
#2Belinda Oyinkan Marquis (Cornell University)H-Index: 2
Last. Zachary M. Grinspan (Cornell University)H-Index: 16
view all 4 authors...
Abstract Objective This study estimates the national prevalence of depression and anxiety among children with epilepsy and determines which demographic variables and comorbidities increase the risk of these psychopathologies. We also compare the rates of depression and anxiety in pediatric epilepsy with those of other chronic health conditions in childhood. Methods We used the 2009–2010 National Survey of Children with Special Health Care Needs to identify children with epilepsy with and without...
9 CitationsSource
#1Mary L. Zupanc (UF: University of Florida)H-Index: 24
#2Bruce H. Cohen (UF: University of Florida)H-Index: 1
Last. William H. TrescherH-Index: 20
view all 8 authors...
In September 2017, the Child Neurology Society (CNS) convened a special task force to review the practice of child neurology in the United States. This was deemed a necessity by our membership, as our colleagues expressed discouragement and burnout by the increase in workload without additional resources; reliance on work relative value units (wRVUs) as the sole basis of compensation; a push by administrators for providers to see more patients with less allotted time; and lack of administrative,...
8 CitationsSource
#1Susan A. Berry (UMN: University of Minnesota)H-Index: 37
#2Curtis R. Coughlin (University of Colorado Denver)H-Index: 20
Last. Cynthia LeMonsH-Index: 8
view all 7 authors...
The National Institutes of Health (NIH) established the Rare Diseases Clinical Research Network to address the unique challenges of performing research on rare diseases. The Urea Cycle Disorders Consortium (UCDC) was one of the original ten consortia established. The UCDC represents a unique partnership among clinicians, patients, and the NIH with a primary goal of increasing the development of therapeutics that improve patient outcomes for persons affected with a UCD. Based in part on financial...
7 CitationsSource
#1Daniel I. Sessler (Monash University)H-Index: 1
#2Paul S. MylesH-Index: 85
SUMMARYLarge randomized trials provide the highest level of clinical evidence. However, enrolling large numbers of randomized patients across numerous study sites is expensive and often takes years. There will never be enough conventional clinical trials to address the important questions in medicin
5 CitationsSource
#1Ellen Wright Clayton (VUMC: Vanderbilt University Medical Center)H-Index: 54
#2Barbara J. Evans (UH: University of Houston)H-Index: 15
Last. Mark A. Rothstein (University of Louisville)H-Index: 34
view all 4 authors...
Recent advances in technology have significantly improved the accuracy of genetic testing and analysis, and substantially reduced its cost, resulting in a dramatic increase in the amount of genetic information generated, analysed, shared, and stored by diverse individuals and entities. Given the diversity of actors and their interests, coupled with the wide variety of ways genetic data are held, it has been difficult to develop broadly applicable legal principles for genetic privacy. This articl...
37 CitationsSource
#1Jinkuk Kim (Harvard University)H-Index: 9
#2Chunguang HuH-Index: 1
Last. Timothy W. YuH-Index: 42
view all 48 authors...
Summary Genome sequencing is often pivotal in the diagnosis of rare diseases, but many of these conditions lack specific treatments. We describe how molecular diagnosis of a rare, fatal neurodegene...
148 CitationsSource
Cited By3
#1Joshua L. Bonkowsky (UofU: University of Utah)H-Index: 28
#2Ryan J. Felling (Johns Hopkins University)H-Index: 4
Last. Gabrielle deVeberH-Index: 85
view all 7 authors...
Abstract Background The past decades have seen a transformational shift in the understanding and treatment for neurological diseases affecting infants and children. These advances have been driven in part by the pediatric neurology physician-scientist workforce and its efforts. However, pediatric neurology research faces significant challenges from internal and external forces including work-life balance demands, COVID-19 pandemic effects, and research funding. Understanding the impact of these ...
#2Priyanka Madaan (CSIR: Council of Scientific and Industrial Research)
Last. Lokesh SainiH-Index: 7
view all 3 authors...
#1Shijia Yu (PRC: China Medical University (PRC))H-Index: 1
#2Mingjun Yu (PRC: China Medical University (PRC))H-Index: 1
Our review aims to highlight the neurological complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the available treatments according to the existing literature, discussing the underlying mechanisms. Since the end of 2019, SARS-CoV-2 has induced a worldwide pandemic that has threatened numerous lives. Fever, dry cough, and respiratory symptoms are typical manifestations of COVID-19. Recently, several neurological complications of the central and peripheral ...
3 CitationsSource